1. Home
  2. Detail

@adnanafzaalfoodsecrets: Foxnuts & Almond Dessert Recipe | Amazing Makhana Badam Halwa Recipe | A Delicious Healthy Dessert #almond #foxnuts #dessert #viral #recipes

Adnan Afzaal Food Secrets
Adnan Afzaal Food Secrets
Open In TikTok:
Region: PK
Wednesday 16 September 2026 08:14:02 GMT
45130
1183
13
171

Music

Download

No Watermark .mp4 (12.98MB) No Watermark(HD) .mp4 (12.98MB) Watermark .mp4 (30.28MB) Music .mp3

Comments

muhammad.tanveer3982
Mahar/King :
Tanveer Ali Sakharghar
2026-09-17 08:01:41
1
user2025313358380
user2025313358380 :
Ayan fsd se
2026-09-17 11:53:50
0
areeshamalik657
areeshamalik657 :
tariq Malik madina town Faisalabad pakistan
2026-09-16 15:42:28
0
muhammad.qamar.iq7
Muhammad Qamar iqbal :
🥰🥰🥰
2026-09-17 07:58:24
0
arshadtaj64
🔥ABDUL🥀 REHMAN,🥵 :
♥️♥️♥️
2026-09-17 06:16:00
0
sajjadadocate
sajjad Advocate. 1 :
❤️
2026-09-16 21:51:07
0
user3058373565160
shani :
😳😳😳
2026-09-16 15:27:52
0
ali.malik0595
Ali Malik :
🥰🥰🥰🥰
2026-09-16 14:04:32
0
tanveer.baloch255
Tanveer Baloch :
😁😁😁
2026-09-16 13:50:48
0
sanaadnan48
Sana Adnan :
🥰🥰🥰🥰
2026-09-16 10:14:41
0
m.ahmad.khan3291
M Ahmad Jutt 124M :
[Heartwarming][Heartwarming][Heartwarming]
2026-09-16 08:56:18
0
m..t..khan119
Ali Talha :
🥰🥰🥰
2026-09-16 08:22:44
0
chriyaz.jutt.3
چوہدری ریاص جٹ🔥 :
😁😁😁
2026-09-17 09:27:13
0
To see more videos from user @adnanafzaalfoodsecrets, please go to the Tikwm homepage.

Other Videos

#kika #raboday #viraltiktok #haitiantiktok🇭🇹
#kika #raboday #viraltiktok #haitiantiktok🇭🇹
#foryoupage #4upage #galaustory #katakatagalau
#foryoupage #4upage #galaustory #katakatagalau
I AM... [Tıtle Card] #invincible #markgrayson #imagecomics #fyp
I AM... [Tıtle Card] #invincible #markgrayson #imagecomics #fyp
When we talk about GLP-1 medications like semaglutide and tirzepatide, the conversation usually centers around diabetes and weight loss. But there may be a much bigger story unfolding. Watch the full episode on YouTube - link in bio Researchers are increasingly interested in the effects GLP-1 receptor agonists may have beyond the scale—including their relationship with systemic inflammation, cardiovascular health, metabolic function, and the brain. That raises an intriguing question: Could very low doses of GLP-1 medications eventually have a role in conditions where chronic inflammation is part of the problem? In this video, I explore why GLP-1 microdosing has caught my attention and the potential implications for conditions such as: • Autoimmune disease • Chronic pain syndromes • PCOS • Mood and mental health conditions • Alzheimer's disease and cognitive decline • Cardiovascular disease It's important to be very clear: GLP-1 microdosing for these conditions is not established medical therapy. We don't yet have large-scale clinical trials showing that microdosing treats or prevents these diseases. What we do have is an expanding body of research into the broader biological effects of GLP-1 receptor agonists—and some fascinating questions worth following. In this conversation, I'll explain what we're learning, what remains unknown, and why careful medical supervision is essential when considering any off-label approach. At Complete Midlife Wellness Center, we believe good medicine requires both evidence and curiosity: following the science we have today while paying close attention to where it may take us tomorrow. 👉 Interested in learning more about our approach to GLP-1 microdosing? Visit CompleteMidlifeWellnessCenter.com to learn more or schedule a consultation.
When we talk about GLP-1 medications like semaglutide and tirzepatide, the conversation usually centers around diabetes and weight loss. But there may be a much bigger story unfolding. Watch the full episode on YouTube - link in bio Researchers are increasingly interested in the effects GLP-1 receptor agonists may have beyond the scale—including their relationship with systemic inflammation, cardiovascular health, metabolic function, and the brain. That raises an intriguing question: Could very low doses of GLP-1 medications eventually have a role in conditions where chronic inflammation is part of the problem? In this video, I explore why GLP-1 microdosing has caught my attention and the potential implications for conditions such as: • Autoimmune disease • Chronic pain syndromes • PCOS • Mood and mental health conditions • Alzheimer's disease and cognitive decline • Cardiovascular disease It's important to be very clear: GLP-1 microdosing for these conditions is not established medical therapy. We don't yet have large-scale clinical trials showing that microdosing treats or prevents these diseases. What we do have is an expanding body of research into the broader biological effects of GLP-1 receptor agonists—and some fascinating questions worth following. In this conversation, I'll explain what we're learning, what remains unknown, and why careful medical supervision is essential when considering any off-label approach. At Complete Midlife Wellness Center, we believe good medicine requires both evidence and curiosity: following the science we have today while paying close attention to where it may take us tomorrow. 👉 Interested in learning more about our approach to GLP-1 microdosing? Visit CompleteMidlifeWellnessCenter.com to learn more or schedule a consultation.
#sohnapind149 #trending #virelvideo #virel #fyp
#sohnapind149 #trending #virelvideo #virel #fyp
🫦🤷‍♀️💫
🫦🤷‍♀️💫

About

Legal